肺癌向治疗.pptVIP

  • 10
  • 0
  • 约2.35万字
  • 约 49页
  • 2018-06-26 发布于福建
  • 举报
肺癌向治疗

* * * Presta et al. Cancer Res. 1997;57:4593. Avastin binds to the VEGF ligand and inhibits VEGF-stimulated signaling events. Bevacizumab is a recombinant humanized monoclonal antibody that binds VEGF. Once bound, Avastin prevents VEGF interactions with VEGFR-1 (Flt-1) and VEGFR-2 (KDR) on the surface of endothelial cells, inhibiting VEGF-stimulated downstream signaling events. * * * * * Interesting that subgrouping the genders revealed survival advantage only for men, not women. * * * * * * * Not otherwise specified, without specific histologic subtype Phase III trial of bevacizumab in NSC

文档评论(0)

1亿VIP精品文档

相关文档